Andrew T Girvin
Overview
Explore the profile of Andrew T Girvin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
1021
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee L, Coelho D, Manzoor N, Wilcox A, Lee A, Graves A, et al.
Otol Neurotol Open
. 2024 Jun;
4(2):e051.
PMID: 38919767
Objective: Determine the incidence of vestibular disorders in patients with SARS-CoV-2 compared to the control population. Study Design: Retrospective. Setting: Clinical data in the National COVID Cohort Collaborative database (N3C)....
2.
Sidky H, Hansen K, Girvin A, Hotaling N, Michael S, Gersing K, et al.
Comput Struct Biotechnol J
. 2024 Feb;
24:115-125.
PMID: 38318198
Background: Post-acute sequelae of COVID-19 (PASC) produce significant morbidity, prompting evaluation of interventions that might lower risk. Selective serotonin reuptake inhibitors (SSRIs) potentially could modulate risk of PASC via their...
3.
Peat T, Gaikwad S, Dubois W, Gyabaah-Kessie N, Zhang S, Gorjifard S, et al.
Cancer Lett
. 2023 Jun;
568:216284.
PMID: 37356470
Drug resistance and disease progression are common in multiple myeloma (MM) patients, underscoring the need for new therapeutic combinations. A high-throughput drug screen in 47 MM cell lines and in...
4.
Pfaff E, Girvin A, Crosskey M, Gangireddy S, Master H, Wei W, et al.
J Am Med Inform Assoc
. 2023 May;
30(7):1305-1312.
PMID: 37218289
Machine learning (ML)-driven computable phenotypes are among the most challenging to share and reproduce. Despite this difficulty, the urgent public health considerations around Long COVID make it especially important to...
5.
Brannock M, Chew R, Preiss A, Hadley E, Redfield S, McMurry J, et al.
Nat Commun
. 2023 May;
14(1):2914.
PMID: 37217471
Long COVID, or complications arising from COVID-19 weeks after infection, has become a central concern for public health experts. The United States National Institutes of Health founded the RECOVER initiative...
6.
Sidky H, Young J, Girvin A, Lee E, Shao Y, Hotaling N, et al.
BMC Med Res Methodol
. 2023 Feb;
23(1):46.
PMID: 36800930
Background: Multi-institution electronic health records (EHR) are a rich source of real world data (RWD) for generating real world evidence (RWE) regarding the utilization, benefits and harms of medical interventions....
7.
Sidky H, Sahner D, Girvin A, Hotaling N, Michael S, Gersing K
medRxiv
. 2022 Nov;
PMID: 36380766
Importance: Post-acute sequelae of COVID-19 (PASC) produce significant morbidity, prompting evaluation of interventions that might lower risk. Selective serotonin reuptake inhibitors (SSRIs) potentially could modulate risk of PASC via their...
8.
Brannock M, Chew R, Preiss A, Hadley E, McMurry J, Leese P, et al.
medRxiv
. 2022 Oct;
PMID: 36238713
Importance: Characterizing the effect of vaccination on long COVID allows for better healthcare recommendations. Objective: To determine if, and to what degree, vaccination prior to COVID-19 is associated with eventual...
9.
Kishton R, Patel S, Decker A, Vodnala S, Cam M, Yamamoto T, et al.
Cell Rep
. 2022 Aug;
40(5):111153.
PMID: 35926468
Adoptive T cell therapies (ACT) have been curative for a limited number of cancer patients. The sensitization of cancer cells to T cell killing may expand the benefit of these...
10.
Pfaff E, Girvin A, Bennett T, Bhatia A, Brooks I, Deer R, et al.
Lancet Digit Health
. 2022 May;
4(7):e532-e541.
PMID: 35589549
Background: Post-acute sequelae of SARS-CoV-2 infection, known as long COVID, have severely affected recovery from the COVID-19 pandemic for patients and society alike. Long COVID is characterised by evolving, heterogeneous...